When did ARCUS BIOSCIENCES INC (RCUS) report earnings last quarter?
ARCUS BIOSCIENCES INC (RCUS) last reported earnings on 2/25/2026.
NYSE:RCUS • US03969F1093
Past quarterly earnings results for ARCUS BIOSCIENCES INC (RCUS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.89 | -1.05 | 14.97% | 13.59% | 33M | 36.425M | -9.40% | 26.92% |
| Q3 2025 | -1.27 | -1.34 | 4.95% | -27.00% | 26M | 21.828M | 19.11% | -45.83% |
| Q2 2025 | 0.00 | -1.15 | 100.00% | 100.00% | 160M | 32.176M | 397.27% | 310.26% |
| Q1 2025 | -1.14 | -1.05 | -8.41% | -2,180.00% | 28M | 37.271M | -24.87% | -80.69% |
| Q4 2024 | -1.03 | -1.27 | 19.13% | 4.63% | 26M | 29.478M | -11.80% | -16.13% |
| Q3 2024 | -1.00 | -1.08 | 7.78% | -6.38% | 48M | 38.307M | 25.30% | 50.00% |
| Q2 2024 | -1.02 | -1.12 | 8.92% | 1.92% | 39M | 26.125M | 49.28% | 34.48% |
| Q1 2024 | -0.05 | -0.97 | 94.85% | 95.41% | 145M | 34.54M | 319.80% | 480.00% |
| Q4 2023 | -1.08 | -1.04 | -3.39% | -16.13% | 31M | 28.935M | 7.14% | -8.01% |
| Q3 2023 | -0.94 | -1.15 | 18.35% | -4.44% | 32M | 27.828M | 14.99% | -4.76% |
| Q2 2023 | -1.04 | -1.12 | 7.19% | -11.83% | 29M | 30.904M | -6.16% | 8.21% |
| Q1 2023 | -1.09 | -1.19 | 8.14% | -13.54% | 25M | 25.467M | -1.83% | 38.89% |
| Q4 2022 | -0.93 | -1.09 | 14.53% | -125.07% | 33.7M | 23.773M | 41.76% | -90.49% |
| Q3 2022 | -0.90 | -1.06 | 14.99% | 18.92% | 33.6M | 22.325M | 50.50% | 253.68% |
| Q2 2022 | -0.93 | -0.96 | 3.18% | 14.68% | 26.8M | 21.548M | 24.37% | 182.11% |
| Q1 2022 | -0.96 | -0.88 | -9.30% | 11.11% | 18M | 27.158M | -33.72% | 89.47% |
| Q4 2021 | 3.71 | -0.76 | 589.04% | 552.44% | 354.5M | 40.175M | 782.39% | 3,631.58% |
| Q3 2021 | -1.11 | -1.10 | -1.15% | -3,800.00% | 9.5M | 9.588M | -0.92% | -85.27% |
| Q2 2021 | -1.09 | -0.89 | -22.28% | -17.20% | 9.5M | 13.316M | -28.66% | 427.78% |
| Q1 2021 | -1.08 | -0.84 | -27.86% | -71.43% | 9.5M | 12.49M | -23.94% | 427.78% |
| Q4 2020 | -0.82 | -0.76 | -7.29% | - | 9.5M | 8.087M | 17.47% | - |
| Q3 2020 | 0.03 | 0.05 | -41.18% | - | 64.5M | 49.113M | 31.33% | - |
| Q2 2020 | -0.93 | -0.62 | -49.04% | - | 1.8M | 1.664M | 8.17% | - |
| Q1 2020 | -0.63 | -0.58 | -9.44% | - | 1.8M | 1.562M | 15.24% | - |
Notes
ARCUS BIOSCIENCES INC (RCUS) last reported earnings on 2/25/2026.
ARCUS BIOSCIENCES INC (RCUS) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, ARCUS BIOSCIENCES INC (RCUS) has beaten EPS estimates in 3 out of 4 releases.